Filing Details

Accession Number:
0001179110-21-010240
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-18 16:06:15
Reporting Period:
2021-11-16
Accepted Time:
2021-11-18 16:06:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1597264 Blueprint Medicines Corp BPMC Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1769740 Ariel Hurley C/O Blueprint Medicines Corporation
45 Sidney Street
Cambridge MA 02139
Principal Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-16 700 $1.87 10,797 No 4 M Direct
Common Stock Acquisiton 2021-11-16 650 $8.80 11,447 No 4 M Direct
Common Stock Acquisiton 2021-11-16 600 $15.01 12,047 No 4 M Direct
Common Stock Disposition 2021-11-16 1,950 $114.28 10,097 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-11-16 700 $0.00 700 $1.87
Common Stock Stock Option (Right to Buy) Disposition 2021-11-16 650 $0.00 650 $8.80
Common Stock Stock Option (Right to Buy) Disposition 2021-11-16 600 $0.00 600 $15.01
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,654 2024-10-08 No 4 M Direct
714 2025-02-10 No 4 M Direct
3,200 2026-02-03 No 4 M Direct
Footnotes
  1. Effected pursuant to a trading plan adopted on March 12, 2021 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  2. This option was granted on October 8, 2014 and is fully vested as of the date hereof.
  3. This option was granted on February 10, 2015 and is fully vested as of the date hereof.
  4. This option was granted on February 3, 2016 and is fully vested as of the date hereof.